Differential sensitivity of naïve and memory subsets of human CD8+ T cells to TNF-α-induced apoptosis

Journal of Clinical Immunology

Volumn 26, Issue 3, 2006, Pages 193-203

  Gupta, Sudhir ^a,b   Su, Houfen ^a   Bi, Ruifen ^a   Gollapudi, Sastry ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apoptosis; Bcl 2; Memory T cells; NF B; TNF

Indexed keywords

CASPASE 3; CASPASE 8; CD8 ANTIGEN; FLICE INHIBITORY PROTEIN; I KAPPA B; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; EFFECTOR CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LYMPHOCYTE FUNCTION; MEMORY T LYMPHOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION;

ADULT; APOPTOSIS; BCL-X PROTEIN; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CASPASE 3; CASPASE 8; CD8-POSITIVE T-LYMPHOCYTES; ENZYME ACTIVATION; HUMANS; I-KAPPA B KINASE; I-KAPPA B PROTEINS; NF-KAPPA B; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; T-LYMPHOCYTE SUBSETS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33745145485     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-006-9019-1     Document Type: Article

References (50)

1. Sallusto F, Geginat J, Lanzavecchia A: Central memory and effector memory T cell subsets: Function, generation, and maintenance. Ann Rev Immunol 22:745-763, 2004
2. Moser B, Loetscher P: Lymphocyte traffic control by chemokines. Nature Immunol 2:123-128, 2001
3. Schluns KS, Lefrancois L: Cytokine control of memory T-cell development and survival. Nature Rev Immunol 3:269-279, 2003
4. Arbones SL, Ord DC, Ley K, Ratech H, Maynard-Cuny C, Otten G, Capon DJ, Tedder TF: Lymphocyte homing and leukocyte rolling and migration are impaired in L-selectin-deficienct mice. Immunity 1:247-260, 1994
5. Campbell JJ, Bowman EP, Murphy K, Youngman KR, Siani MA, Thompson DA, Wu L, Zlotnik A, Butcher EC: 6-C-kine (SLC), a lymphocyte adhesion-triggering chemokine expressed by high endothelium, is an agonist for MIP-13β receptor (CCR7). J Biol Chem 414:1053-1059, 1998
6. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A: Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401:708-712, 1999
7. Kataoka T, Budd RC, Holler N, Thome M, Martinon F, Irmler M, Burns K, Masopust D, Vezys V, Marzo AL, Lanzavecchia A: Preferential localization of effector memory cells in nonlymphoid tissue. Science 291:2413-2417, 2001
8. Weninger W, Crowley MA, Manjunath N, von Andriane UH: Migratory properties of naïve, effector, and memory CD8 (+) T cells. J Exp Med 194:953-966, 2001
9. Tomiyama H, Matsuda T, Takiguchi M: Differentiation of CD8+ T cells from a memory to memory/effector phenotype. J Immunol 168:5538-5550, 2002
10. Waring P, Kos FJ, Mullbacher A: Apoptosis or programmed cell death. Med Res Rev 11:219-236, 1991
11. Hengartner MO: The biochemistry of apoptosis. Nature 407:770-776, 2000
12. Krammer PH: CD95's deadly mission in the immune system. Nature 407:789-795, 2000
13. Green DR, Evan GI: A matter of life and death. Cancer Cell 1:19-30, 2002
14. Gupta S: Molecular steps of TNF receptor-mediated apoptosis. Curr Mol Med 1:299-306, 2002
15. Gupta S: A decision between life and death during TNF-α-induced signaling. J Clin Immunol 22:270-278, 2002
16. Rath PC, Aggarwal BB: TNF-induced signaling in apoptosis. J Clin Immunol 19:350-364, 1999
17. Wajant H, Pfizenmaieer K, Scheurich P: Tumor necrosis factor signaling. Cell Death Differ 10:45-65, 2003
18. Ghosh S, Karin M: Missing pieces in the NF-κB puzzle. Cell 109:S81-S96, 2002
19. Karin M, Lin A: NF-κB at the crossroads of life and death. Nature Immunol 3:221-227, 2002
20. Beg AA, Baltimore D: An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274:782-784, 1996
21. Li Q, Verma IM: NF-κB regulation in the immune system. Nature Rev Immunol 2:725-734, 2002
22. Gupta S, Bi R, Su K, Yel L, Chiplunkar S, Gollapudi S: Characterization of naïve, memory, and effector CD8+ T cells: Effect of age. Exp Gerontol 39:545-550, 2004
23. L. Cell Death Diff 10:1032-1044, 2003
24. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS, Jr: NF-κB anti-apoptosis: Induction of TRAF1 and TRAF2 and cIAP1 and cIAP2 to suppress caspase-8 activation. Science 281:1680-1683, 1998
25. Tamatan M, Che WH, Matsuzaki H, Ogawa S, Okado H, Miyake S, Mizuno T, Tohyama M: Tumor necrosis factor-induces Bcl-2 and Bcl-x expression through NF-κB activation in primary hippocampus neurons. J Biol Chem 274:8531-8538, 1999
26. Bentires-Alj M, Dejardin E, Viatour P, Van Lint C, Froesch B, Reed JC, Merville MP, Bours V: Inhibition of the NF-kappa B transcription factor increases Bax expression in cancer cell lines. Oncogene 20:2805-2813, 2001
27. Thome M, Tschopp J: Regulation of lymphocyte proliferation and death by FLIP. Nature Rev Immunol 1:50-58, 2001
28. Muppidi JR, Tschopp J, Siegel RM: Life and death decisions: Secondary complexes and lipid rafts in TNF receptor family signal transduction. Immunity 21:461-465, 2004
29. Pimental-Muinos FX, Seed B: Regulated commitment of TNF receptor signaling: A molecular switch for death or activation. Immunity 18:3034-3043, 1999
30. Declercz W, Denecker G, Fiers W, Vandenabeele P: Cooperation of both TNF receptors in inducing apoptosis: Involvement of the TNF receptor-associated factor binding domain of the TNF receptor 75. J Immunol 161:390-399, 1998
31. Haridas V, Darnay BG, Natrajan K, Helle R, Aggarwal BB: Overexpression of the p80 TNFR leads to TNF-dependent apoptosis, nuclear factor-kappa B activation. J Immunol 160:3152-3162, 1998
32. Weiss T, Grell M, Siekienski K, Muhlenbeck F, Durkop H, Pfizenmaier K, Scheurich P, Wajant H: TNFR80-dependent enhancement of TNFR60-induced cell death is mediated by TNFR-associated factor 2 and is specific for TNFR60. J Immunol 161:3136-3142, 1998
33. Chen FK, Lenardo MJ: A crucial role for p80 TNF-R2 in amplifying p60 TNF-R1 apoptosis signals in T lymphocytes. Eur J Immunol 30:652-660, 2002
34. Vandenabeele P, Declercq W, Vanhaesebroeck B, Grooten J, Fiers W: Both TNF receptors are required for TNF-mediated induction of apoptosis in PC60 cells. J Immunol 154:2904-2913, 1995
35. Tartaglia L, Pennica D, Godde DVL: Ligand passing: The 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the p55-kDa TNF receptor. J Biol Chem 268:18542-18548, 1993
36. Devin A, Cook A, Lin Y, Rodriguez Y, Kelliher M, Liu Z-G: The distinct role of TRAF2 and RIP in IKK activation by TNFR1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. Immunity 12:419-429, 2000
37. Kelliher MA, Grimm S, Ishida Y, Kuo F, Stanger BZ, Leader P: The death domain kinase RIP mediates the TNF-induced NF-κB signal. Immunity 8:297-303, 1998
38. Micheau O, Lens S, Gaide O, Alevizopolous K, Tschopp I: NF-κB signals induce the expression of c-FLIP. Mol Cell Biol 21:5299-5305, 2001
39. Irmler M, Thome M, Hahne M, Schnieder P, Hoffmann K, Steiner V, Bodmer J-L, Schroter M, Burns K, Mattmann C, Rimoldi D, French LE, Tschopp J: Inhibition of death receptor signals by cellular FLIP. Nature 388:190-195, 1997
40. MIcheau O, Tschopp J: Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114:181-190, 2003
41. Kataoka T, Budd RC, Holler N, Thome M, Martinon F, Irmler M, Burns K, Hahne M, Kennedy N, Koacsovics M, Tschopp J: The caspase inhibitor FLIP promotes activation of NF-κB and ERK signaling pathways. Curr Biol 10:640-648, 2000
42. Dohrman A, Kataoka T, Cuenin S, Russell RQ, Tschopp J, Budd RC: Cellular FLIP (long form) regulates CD8+ T cells activation through caspase-8-dependent NF-κB activation. J Immunol 174:5270-5278, 2005
43. Li H, Zhu H, Xu C, Yuan J: Cleavage of Bid by caspase-8 mediates mitochondrial damage in the Fas pathway of apoptosis. Cell 94:491-501, 1998
44. Zhang N, He Y-W: The anti-apoptotic protein Bcl-xL is dispensable for the development of effector and memory T lymphocytes. J Immunol 174:6967-6973, 2005
45. Sprent J: Turnovere of memory phenotype CD8+ T cells. Microbes Infect 5:227-231, 2003
46. Wherry EJ, Teichgraber V, Becker TC, Masopust D, Kaech SM, Antia R, von Andrian UH, Ahmed R: Lineage relationship and protective immunity of memory CD8+ T cell subsets. Nature Immunol 4:225-234, 2003
47. Monteiro J, Baltiwala F, Ostere H, Gregersen PK: Shortened telomere in clonally expanded CD28-CD8+ T cells imply a replicative history that is distinct from there CD28+CD8+ counterparts. J Immunol 156:3587-3590, 1996
48. Alpdogan O, van den Brink MRM: IL-7 and IL-15: Therapeutic cytokines for immunodeficiency. Trends Immunol 26:56-64, 2005
49. Berard M, Brandt K, Bulfone-Paus S,Tough DF: IL-15 promotes the survival of naive and memory phenotype CD8+ T cells. J Immunol 171:5018-5026, 2003
50. Petrovas C, Mueller YM, Dimitriou ID, Bojczuk PM, Mounzer KC, Witek J, Altman JD, Katsikis PD: HIV-specific CD8+ T cells exhibit markedly reduced levels of Bcl-2 and Bcl-xL. J Immunol 172:4444-4453, 2004